Irene Pignata
Overview
Explore the profile of Irene Pignata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baratta F, Pignata I, Ravetto Enri L, Brusa P
J Pharm Policy Pract
. 2025 Feb;
18(1):2456382.
PMID: 39931674
Background: In many countries in Europe and in the world, pharmacists are allowed to prescribe or modify therapies. In Italy, the only healthcare professions authorised to prescribe are medical doctors...
2.
Baratta F, Pignata I, Vicenzi G, Ravetto Enri L, Quaglino P, Comandone A, et al.
Pharm Pract (Granada)
. 2023 Feb;
20(4):2716.
PMID: 36793913
Objective: To investigate the role of community pharmacists in the therapeutic process of oncological patients and to assess these patients' state of acceptance of their disease and their relationship with...
3.
Spadea T, Onorati R, Baratta F, Pignata I, Parente M, Pannacci L, et al.
PLoS One
. 2021 Sep;
16(9):e0256478.
PMID: 34492060
Introduction: Type 2 diabetes is an important public health issue, yet adherence to drugs and regular clinical follow-up is still suboptimal. This study aims to evaluate a community pharmacy programme...
4.
Brusa P, Pignata I
Recenti Prog Med
. 2021 Aug;
112(9):565-569.
PMID: 34392320
The deontological duties of the pharmacist recommend advising customers on the correct use of medicines. In addition, they recommend giving the citizen up-to-date and complete information on drugs, understandable to...
5.
Baratta F, Simiele M, Pignata I, Ravetto Enri L, DAvolio A, Torta R, et al.
Pharmaceuticals (Basel)
. 2021 Mar;
14(2).
PMID: 33671760
Current legislation in Italy provides that medical may be administered orally or by inhalation. One of the fundamental criteria for the administration of oral formulations is that they deliver a...
6.
Baratta F, Visentin G, Ravetto Enri L, Parente M, Pignata I, Venuti F, et al.
Int J Environ Res Public Health
. 2021 Mar;
18(5).
PMID: 33652711
Pharmacists in the community and the essential requirement to safeguard their own health have become fundamental since the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The aims...
7.
Fanelli E, Ravetto Enri L, Pappaccogli M, Fasano C, Di Monaco S, Pignata I, et al.
Nutr Metab Cardiovasc Dis
. 2021 Feb;
31(4):1081-1086.
PMID: 33618921
Backgrounds And Aims: Hypertension is a risk factor for renal, cardiovascular and cerebrovascular diseases. It is responsible for a large proportion of overall morbidity and mortality every year. Hypertension-mediated organ...
8.
Gallone E, Ravetto Enri L, Pignata I, Baratta F, Brusa P
Health Policy
. 2020 Sep;
124(12):1281-1286.
PMID: 32994057
Italy is the last European country to adopt policies on the liberalization of pharmacy ownership. In August 2017, the Italian government approved the law n. 124 (annual market and competition...
9.
Parente M, Pignata I, Gnavi R, Spadea T, Di Martino M, Baratta F, et al.
Patient Prefer Adherence
. 2020 Feb;
14:261-266.
PMID: 32103910
Introduction: It is not possible to recover from chronic diseases; however, a healthy lifestyle and correct adherence to therapy can avoid complications and co-morbidities. The aim of this study was...
10.
Pignata I, Vicenzi G, Ravetto Enri L, Baratta F, Quaglino P, Comandone A, et al.
Ital J Dermatol Venerol
. 2019 Sep;
156(Suppl. 1 to No. 6):79-80.
PMID: 31525843
No abstract available.